rs62346982
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_001364905.1(LRBA):c.7564A>C(p.Thr2522Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00698 in 1,612,060 control chromosomes in the GnomAD database, including 52 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001364905.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LRBA | NM_001364905.1 | c.7564A>C | p.Thr2522Pro | missense_variant | 50/57 | ENST00000651943.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LRBA | ENST00000651943.2 | c.7564A>C | p.Thr2522Pro | missense_variant | 50/57 | NM_001364905.1 | P3 |
Frequencies
GnomAD3 genomes ? AF: 0.00447 AC: 679AN: 152006Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00424 AC: 1051AN: 248108Hom.: 6 AF XY: 0.00408 AC XY: 548AN XY: 134150
GnomAD4 exome AF: 0.00725 AC: 10581AN: 1459936Hom.: 52 Cov.: 31 AF XY: 0.00701 AC XY: 5092AN XY: 726282
GnomAD4 genome ? AF: 0.00446 AC: 679AN: 152124Hom.: 0 Cov.: 32 AF XY: 0.00395 AC XY: 294AN XY: 74374
ClinVar
Submissions by phenotype
Combined immunodeficiency due to LRBA deficiency Uncertain:1Benign:4
Likely benign, criteria provided, single submitter | clinical testing | Genetics and Molecular Pathology, SA Pathology | Aug 18, 2020 | BS1, BP4 - |
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Oct 31, 2023 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Nov 15, 2017 | - - |
Benign, criteria provided, single submitter | clinical testing | Invitae | Jan 31, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago | Oct 04, 2022 | This variant has been reported in the literature in 1 individual with panuveitis (Li 2021 PMID:32707200). This variant is present in the Genome Aggregation Database (Highest reported MAF 0.7% (543/67998) (https://gnomad.broadinstitute.org/variant/4-150321257-T-G?dataset=gnomad_r3). This variant is present in ClinVar, with several labs classifying this variant as Likely Benign or Benign (Variation ID:439869). Evolutionary conservation and computational predictive tools suggest that this variant may not impact the protein. In summary, data on this variant suggests that this variant does not cause disease but requires further evidence. Therefore, this variant is classified as likely benign. - |
not specified Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Mar 02, 2020 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jun 22, 2017 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Apr 01, 2024 | LRBA: BP4, BS2 - |
LRBA-related disorder Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | May 10, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at